|
|
|
|
|
||
|
|||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
Journal of Cell Science, Vol 110, Issue 2 139-148, Copyright © 1997 by Company of Biologists
JOURNAL ARTICLES |
EG Levin, L Santell and KG Osborn
Department of Molecular and Experimental Medicine, Scripps Research Institute, La Jolla, CA 92037, USA.
Plasma tissue plasminogen activator (tPA) has long been considered to be the product of the endothelial cells that line the various parts of the vascular system regardless of vessel size or location. To determine whether this was truly the case in vivo, the distribution of tPA in the endothelium of the mouse lung and other tissues was evaluated. Immunohistochemical analysis of normal lung tissue showed positive staining limited to the endothelial cells of the bronchial arteries regardless of size with few cells of the pulmonary circulation associated with tPA. The pulmonary vessels that did contain endothelial cell-derived tPA were consistently between 7 and 30 microns in diameter. No capillary or large vessel pulmonary endothelium ever stained positive. These results were also observed in primate lung tissue where the bronchial endothelium of all vessels, even down to capillary size, contained tPA while none of the pulmonary endothelium did. Prolonged exposure of mice to hyperoxic conditions promotes acute lung injury and associated inflammation. Using this model, the effect of inflammation on endothelial cell tPA expression was evaluated. A 4.5-fold increase in the number of pulmonary vessels staining positive for tPA was observed after 66 hours with all of these vessels having a diameter between 7 and 30 microns. Again, none of the endothelium of large arteries or veins nor the capillaries had tPA. Whole tissue tPA mRNA increased dramatically with hyperoxia and in situ hybridization analysis showed tPA mRNA in the endothelium of the same types of vessels as antigen. The tPA localized to both the bronchial and pulmonary endothelium was active with neither tPA-PAI-1 complexes nor urokinase found in perfused lung tissue. These results indicate that endothelial cell tPA expression, either constitutive or induced by a pathologic event, is a function of a highly select group of endothelial cells which are defined by their association with vessels of discrete size and/or anatomic location. Thus, the widely held concept that the steady state level of plasma tPA is maintained through its constitutive production by all endothelial cells of the vascular system is invalid. Also suggested is the possibility that endothelial cell tPA might play a broader role than simply maintaining vessel patency as a component of the fibrinolytic pathway and contribute to complex dynamic processes such as inflammation.
This article has been cited by other articles:
|
|
 |
|
  S. V. Pizzo Annexin 2/Factor Xa-Mediated Signal Transduction Circ. Res., February 29, 2008; 102(4): 389 - 391. [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Hao, C. Guo, X. Jiang, S. Krueger, T. Pietri, S. Dufour, R. E. Cone, and J. O'Rourke New transgenic evidence for a system of sympathetic axons able to express tissue plasminogen activator (t-PA) within arterial/arteriolar walls Blood, July 1, 2006; 108(1): 200 - 202. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Mackman Tissue-Specific Hemostasis in Mice Arterioscler. Thromb. Vasc. Biol., November 1, 2005; 25(11): 2273 - 2281. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Gveric, B. M. Herrera, and M. L. Cuzner tPA Receptors and the Fibrinolytic Response in Multiple Sclerosis Lesions Am. J. Pathol., April 1, 2005; 166(4): 1143 - 1151. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N.-L. Pham, A. Franzen, and E. G. Levin NF1 Regulatory Element Functions as a Repressor of Tissue Plasminogen Activator Expression Arterioscler. Thromb. Vasc. Biol., May 1, 2004; 24(5): 982 - 987. [Abstract] [Full Text]
|
|
|
|
 |
|
 P Connor and B J Hunt Cerebral haemostasis and antiphospholipid antibodies Lupus, December 1, 2003; 12(12): 929 - 934. [Abstract] [PDF]
|
|
|
|
 |
|
 X. Wang, L. Xu, H. Wang, R. Grzanna, Y. Zhan, R. M. Knabb, J. M. Luettgen, T. A. Bozarth, R. A. Galemmo, P. C. Wong, et al. Inhibition of Factor Xa Reduces Ischemic Brain Damage After Thromboembolic Stroke in Rats Stroke, February 1, 2003; 34(2): 468 - 474. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-C. Murciano, D. Harshaw, D. G. Neschis, L. Koniaris, K. Bdeir, S. Medinilla, A. B. Fisher, M. A. Golden, D. B. Cines, M. T. Nakada, et al. Platelets inhibit the lysis of pulmonary microemboli Am J Physiol Lung Cell Mol Physiol, March 1, 2002; 282(3): L529 - L539. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. G. Levin, C. L. Banka, and G. C. N. Parry Progressive and Transient Expression of Tissue Plasminogen Activator During Fetal Development Arterioscler. Thromb. Vasc. Biol., June 1, 2000; 20(6): 1668 - 1674. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M Wileman, N. A Booth, N. Moore, B. Redmill, J. V Forrester, and R. M Knott Regulation of plasminogen activation by TGF-beta in cultured human retinal endothelial cells Br. J. Ophthalmol., April 1, 2000; 84(4): 417 - 422. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. Bertuglia and A. Colantuoni Protective effects of leukopenia and tissue plasminogen activator in microvascular ischemia-reperfusion injury Am J Physiol Heart Circ Physiol, March 1, 2000; 278(3): H755 - H761. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Rosnoblet, U. M. Vischer, R. D. Gerard, J.-C. Irminger, P. A. Halban, and E. K. O. Kruithof Storage of Tissue-Type Plasminogen Activator in Weibel-Palade Bodies of Human Endothelial Cells Arterioscler. Thromb. Vasc. Biol., July 1, 1999; 19(7): 1796 - 1803. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Yamamoto, V. de Waard, C. Fearns, and D. J. Loskutoff Tissue Distribution and Regulation of Murine von Willebrand Factor Gene Expression In Vivo Blood, October 15, 1998; 92(8): 2791 - 2801. [Abstract] [Full Text] [PDF]
|
|
